miRNA |
miR-194-5p |
BCLAF1 |
[21] |
miR-628 |
IGF-1R |
[22] |
miR-143 |
Autophagy |
[23] |
miR-126 |
SHIP1 and CEBPB |
[24,25] |
miR-133 |
Evi1 |
[26] |
miR-223 |
G1/S cell cycle |
[27,28,29] |
miR-181a |
Cell proliferation and enhanced cell cycling |
[30] |
miR-128 |
Apoptosis, genome instability, and drug sensitivity |
[31] |
miR-125b |
Cell survival and lowered apoptosis |
[32] |
miR-222 |
ETS1 |
[33] |
miR-223 |
FOXO1 |
[34] |
miR-142-3p |
Drug resistance |
[35] |
miR-26b |
PIK3CD |
[36] |
miR-26 |
Ikaros |
[37] |
miR-30a |
NOTCH1 and NOTCH2 |
[38] |
miR-221 |
STAT5 |
[39] |
miR-497 |
CDKN2A/B |
[40] |
miR-328 |
MALAT1 |
[41] |
miR-214 |
ABCB1 |
[42] |
miR-10a |
USF1 |
[43] |
miR-203 |
Proliferation |
[44] |
miR-29b |
Abl-1 |
[45] |
miR-320 |
ABL |
[46] |
miR -181a and miR-181b |
Drug resistance |
[47,48] |
miR-125b |
GRK2 and PUMA |
[49] |
lncRNA |
RP11-137H2.4 |
NR3C1 |
[50] |
CRNDE |
Proliferation |
[51] |
PVT1 |
Myc |
[52] |
TUG1 |
Proliferation |
[53] |
CCAT1 |
Proliferation and myeloid cell differentiation |
[54] |
NR-104098 |
EZH2 |
[55] |
LINC00265 |
PI3K-Akt |
[56] |
NEAT1 |
Proliferation and drug resistance |
[57] |
HOTAIR |
MRP1 |
[58,59] |
SGNH5 |
Drug resistance |
[60] |
Hmrhl |
Tumor development |
[61] |
circRNA |
Circ-DLEU2 |
proliferation |
[62] |
Circ_0004277 |
miR-134-5p and SSBP2 |
[63] |
CircSPI1 |
SPI1 |
[64] |
CircMYBL2 |
FLT3 |
[65,66,67] |
Circ _004136 |
miR-142 and miR-29a |
[68] |
CircRNF13 |
miR-1224-5p |
[69] |
Circ_0121582 |
miR-224 |
[70] |
Circ_100290 |
miR-203 |
[71] |
Circ_0079480 |
miR-655-3p |
[72] |
Circ_0002483 |
Cell proliferation and cell cycle arrest |
[73] |
CircBA1 |
Cell growth and medication resistance |
[74] |
CircCRKL |
miR-877-5p |
[75] |
Circ-0058493 |
miR-548b-3p |
[76] |
Circ-0132266 |
miR-337-3p |
[77] |
CircZNF91 |
miR-1283 |
[78] |
HOXB-AS3 |
Ribosomal RNA transcription |
[79] |
piRNA and snoRNA |
11186 |
CDKN2B |
[80] |
823 |
DNA methylation and angiogenesis |
[81] |
SNORD42A |
Proliferation |
[82] |
SNHG12 |
miR-195 |
[83] |